Status:
COMPLETED
Towards Understanding the Phenotype of Cardiovascular Disease in CKD - TRUE-Type-CKD Study
Lead Sponsor:
Johann Wolfgang Goethe University Hospital
Conditions:
Heart Failure
Cardiomyopathies
Eligibility:
All Genders
18+ years
Brief Summary
Premature cardiovascular disease (CVD) is the leading cause of death in patients with kidney disease (CKD). Excessive cardiac mortality is thought to be secondary to non-atherosclerotic processes, wit...
Eligibility Criteria
Inclusion
- Adults \>18 years of age
- Able to provide informed consent
- Chronic kidney disease stages G3-5 (eGFR\<59 ml/min/1.73m2)
Exclusion
- Absence of absolute clinical indication for MRI studies (MR unsafe or incompatible devices, aneurysm clips, cochlear implants, loose metal foreign objects)
- Absolute contraindications to gadolinium contrast agent (previous allergic reaction or pregnancy),
Key Trial Info
Start Date :
March 28 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 14 2021
Estimated Enrollment :
276 Patients enrolled
Trial Details
Trial ID
NCT03749551
Start Date
March 28 2018
End Date
June 14 2021
Last Update
January 6 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Frankfurt
Frankfurt am Main, Hesse, Germany, Frankfurt am Main